Exhibit
10.7


 


CONSULTING
AGREEMENT


 


THIS
AGREEMENT made this 30th day of April (the “Effective Date”) between Slinger Bag Inc., a Nevada company
(the “Company”) and Aitan Zacharin, an individual residing in Bet Shemesh, Israel (the “Consultant”)


 


A.
The Company is engaging Consultant as a consultant in respect of investor relations, corporate structure, public relations and
commercial development.


 


B.
The Company and the Consultant wish to formally record the terms and conditions of such engagement.


 


C.
Each of the Company and the Consultant has agreed to the terms and conditions set forth in this Agreement, as evidenced by their
respective execution hereof.


 


NOW
THEREFORE THIS AGREEMENT WITNESSES that, in consideration of the premises and the mutual covenants and agreements herein contained,
the parties hereto covenant and agree as follows:


 


ARTICLE
1


CONTRACT
FOR SERVICES


 


1.1
Engagement of Consultant. The Company hereby agrees to engage the Consultant in accordance with the terms and provisions
hereof.


 


	 	(a)	Term.
    Unless terminated earlier in accordance with the provisions hereof, this Agreement will commence on the Effective Date
    and will continue for a period of three (3) years therefrom (the “Term”).
	 	 	 
	 	(b)	Service.
    The Consultant agrees to faithfully, honestly and diligently serve the Company and to devote the time, attention efforts
    to further the business interests of the Company and utilize his professional skills and care during the Term.


 


1.2
Duties : The Consultant’s services hereunder will be provided on the basis of the following terms and conditions:


 


	 	(a)	The
    Consultant will report directly to the chief executive officer and/or other officers of the Company;
	 	 	 
	 	(b)	The
    Consultant will be responsible for advising on and facilitating the Company’s investor relations, corporate structure
    and governance, public relations and commercial development activities and supervising, liaising and instructing outside service
    providers, in each case, subject to any applicable law and to instructions provided by the officers of the Company from time
    to time.


 




    	 



    	2



    

 


	 	(c)	The
    Consultant will faithfully, honestly and diligently serve the Company and cooperate with the Company and utilize maximum professional
    skill and care to ensure that all services rendered hereunder are to the satisfaction of the Company, acting reasonably, and
    the Consultant will provide any other services not specifically mentioned herein, but which by reason of the Consultant’s
    capability, the Consultant knows or ought to know to be necessary to ensure that the best interests of the Company are maintained.
	 	 	 
	 	(d)	The
    Consultant will assume, obey, implement and execute such duties, directions, responsibilities, procedures, policies and lawful
    orders as may be determined or given from time to time by the Company.
	 	 	 
	 	(e)	The
    Consultant will report the results of his duties hereunder to the Company as it may request from time to time.


 


Article
2 COMPENSATION


 


2.1
Remuneration. 


 


	 	(a)	The
    Consultant’s monthly base consulting fee shall be three thousand two hundred fifty United States dollars ($3,250 (together
    with any increases thereto as hereinafter provided, the “Base Consulting Fee”) through 19 August 2020. Commencing
    on 20 August 2020, Consultant’s Base Consulting Fee shall be increased to $8,500 per calendar month. The Base Consulting
    Fee shall be payable in accordance with the Company’s normal payroll procedures in effect from time to time. All subsequent
    monthly payments of Base Consulting Fee shall be paid within the first five days of the following calendar month. The Base
    Consulting Fee may be increased by the Board from time to time during the Term, but shall be reviewed by the Board at least
    annually
	 	 	 
	 	(b)	The
    Company shall also issue Consultant as soon as reasonably practicable warrants to purchase 1,250,000 shares of common stock
    in the form attached hereto as Annex A. The Company agrees to bear all costs and fees to be charged by the Company’s
    transfer agent in respect of such shares. 
	 	 	 
	 	(c)	The
    Consultant shall be eligible to participate in benefit plans currently and hereafter maintained by the Company of general
    applicability to other consultants of the Company. Subject to the following sentence, the Consultant will be entitled to receive
    up to a one-time bonus of 1,500,000 shares of common stock of the Company promptly after the value of the Company’s
    outstanding stock equals $100 million dollars.
	 	 	 
	 	(d)	In
    addition to the foregoing, the Company will grant the Consultant additional compensation in the form of cash or shares in
    cases of extraordinary contribution by him to the benefit of the Company as the Board of Directors of the Company will decide.


 




    	 



    	3



    

 





2.2
Incentive Plans.  The Consultant will be entitled to participate in any bonus plan or incentive compensation plans (including,
without limitation, equity or option plans) for consultants or outside service-providers adopted by the Company. The Consultant’s
bonus payment level will be set at a minimum of 25% of the annual gross Base Consulting
Fee. It is agreed that any such plans will be retroactive to the Effective Date.


2.3
Expenses.  The Consultant will be reimbursed by the Company for all reasonable business expenses incurred by the Consultant
in connection with his duties. This includes, but is not limited to, payments of expenses incurred when traveling abroad and others.
In this connection, the Consultant will be issued, as soon as practicable, a Company credit card that the Consultant will use
to pay for any and all expenses that pertain to the Company.




 


ARTICLE
3


CONFIDENTIALITY
AND NON-COMPETITION


 


3.1
Maintenance of Confidential Information. 


 


	 	(a)	The
    Consultant acknowledges that, in the course of performing his obligations hereunder, the Consultant will, either directly
    or indirectly, have access to and be entrusted with confidential information (whether oral, written or by inspection) relating
    to the Company or its respective affiliates, associates or customers (the “Confidential Information”).
	 	 	 
	 	(b)	The
    Consultant acknowledges that the Company’s Confidential Information constitutes a proprietary right, which the Company
    is entitled to protect. Accordingly, the Consultant covenants and agrees that, as long as he works for the Company, the Consultant
    will keep in strict confidence the Company’s Confidential Information and will not, without prior written consent of
    the Company, disclose, use or otherwise disseminate the Company’s Confidential Information, directly or indirectly,
    to any third party.
	 	 	 
	 	(c)	The
    Consultant agrees that, upon termination of his services for the Company, he will immediately surrender to the Company all
    Company Confidential Information then in his possession or under his control.





 


3.2
Exceptions. The general prohibition contained in Section 4.1 against the unauthorized disclosure, use or dissemination
of the Company’s Confidential Information will not apply in respect of any Company Confidential Information that:


 


	 	(a)	is
    available to the public generally;
	 	 	 
	 	(b)	becomes
    part of the public domain through no fault of the Consultant;
	 	 	 
	 	(c)	is
    already in the lawful possession of the Consultant at the time of receipt of the Company’s Confidential Information;
    or
	 	 	 
	 	(d)	is
    compelled by applicable law or regulation to be disclosed, provided that the Consultant gives the Company prompt written notice
    of such requirement prior to such disclosure and provides commercially reasonable assistance at the request and expense of
    the Company, in obtaining an order protecting the Company’s Confidential Information from public disclosure.


 




    	 



    	4



    

 


ARTICLE
4 TERMINATION


 


4.1
  Termination of Engagement. The Consultant’s engagement may be terminated only as follows:


 


	 	(a)	Termination
    by the Company


 


	 	(i)	For
    Cause. The Company may terminate the Consultant’s engagement for Cause.
	 	 	 
	 	(ii)	Without
    Cause. The Company may terminate Consultant’s engagement at any time by giving Consultant 60 days prior written Notice
    of the termination. In such case, 100% of the Consultant’s unvested stock and, if applicable, option or warrant compensation
    of any nature will vest without any further action required on the part of the Consultant or the Company and the Company will
    deliver to the order of the Consultant promptly upon receipt of a written demand of the Consultant such shares of common stock
    or options at its sole expense as become due to Consultant hereunder. The Consultant’s right to receive compensation
    whether in cash or securities shall survive any termination of this Agreement Without Cause.


 


	 	(b)	Termination
    by the Consultant


 


	 	(i)	For
    Good Reason. The Consultant may terminate the Consultant’s engagement with the Company for Good Reason.
	 	 	 
	 	(ii)	Without
    Good Reason. The Consultant may voluntarily terminate the Consultant’s engagement with the Company at any time by giving
    the Company 120 days prior written Notice of the termination.


 


	 	(c)	Termination
    Upon Death or Disability


 


	 	(i)	Death.
    The Consultant’s engagement shall terminate upon the Consultant’s death.
	 	 	 
	 	(ii)	Disability.
    The Company may terminate the Consultant’s engagement upon the Consultant’s Disability.


 


	 	(d)	For
    the purpose of this Article 3, “Cause” means:


 


	 	(i)	Breach
    of Agreement. Consultant’s material breach of Consultant’s obligations of this Agreement, not cured after 30 days’
    Notice from the Company.


 




    	 



    	5



    

 


	 	(ii)	Gross
    Negligence. Consultant’s gross negligence in the performance of Consultant’s duties.
	 	 	 
	 	(iii)	Crimes
    and Dishonesty. Consultant’s conviction of or plea guilty to any crime involving, dishonesty, fraud or moral turpitude.
	 	 	 
	 	(iv)	In
    the event of termination of this agreement for Cause, the Company may terminate the Consultant’s engagement after 30
    days’ Notice.


 


	 	(e)	For
    the purpose of this Article 5, “Good Reason” means:


 


	 	(i)	Breach
    of Agreement. The Company’s material breach of this Agreement, which breach has not been cured by the Company within
    30 days after receipt of written notice specifying, in reasonable detail, the nature of such breach or failure from Consultant.
	 	 	 
	 	(ii)	Non
    Payment. The failure of the Company to pay any amount due to Consultant hereunder, which failure persists for 30 days after
    written notice of such failure has been received by the Company.
	 	 	 
	 	(iii)	Change
    of Responsibilities/Compensation. Any material reduction in Consultant’s title or a material reduction in Consultant’s
    duties or responsibilities or any material adverse change in Consultant’s Base Consulting Fee or any material adverse
    change in Consultant’s benefits.


 


	 	(f)	It
    is agreed that in the event of termination of this agreement if the Company decides that the Consultant’s services are
    not needed during the termination period, the Company will continue to be responsible for paying cash and equity compensation
    as defined in Article 2 of this Agreement for the entire termination period. Neither the Company, nor the Consultant will
    be entitled to any notice or payment in excess of that specified in this Article 5.
	 	 	 
	 	(g)	Upon
    the termination (whether for cause, disability, death, without cause, or by way of change of control), the Company shall pay
    to Consultant on the date required under applicable law: (i) any accrued but unpaid Base Consulting Fee for services rendered
    as of the date of termination, (ii) (if applicable) any accrued but unpaid vacation pay, and (iii) the business expenses reasonably
    incurred by the Consultant up to the date of termination or resignation and properly reimbursable, in each case less any applicable
    deductions or withholdings required by law.


 


Section
4.2 Termination for Cause, Disability or Death


 


	 	(a)	In
    the event that this Agreement and the Consultant’s engagement with the Company is terminated for Cause, the Company
    shall provide the Consultant written notice thereof and Consultant or Consultants surviving next of kin shall be entitled
    only to the amounts specified in Section 3.1. plus all vested common shares and, if applicable options and warrants.


 




    	 



    	6



    

 


 


	 	(b)	In
    the event of the Consultants service terminates by reason of the Consultants disability or death, the accrued salary may be
    paid, and options and warrants may be exercised by the by the Consultant or the Consultant’s legal representatives,
    executors or assigns, as the case may be, for a period of one (1) year from the date of death or disability.


 


Section
4.3 Termination without Cause


 


In
the event this Agreement and the Consultant’s engagement with the Company is terminated by the Company without Cause (other
than for death or Disability or in connection with a change of control), then in addition to the amounts specified in Section
4.1 and subject to the Consultant’s execution and non-revocation of a separation agreement containing a general release
and waiver of liability against the Company and anyone connected with it in form acceptable to the Company, the Consultant shall
be entitled to receive, and the Company shall pay the Consultant, two (2) years Base Consulting Fee (less statutory deductions
and withholdings) in a single lump sum, paid in full within 30 days of termination. Further, Consultant shall be entitled to all
vested common shares and, if applicable, options and warrants with vesting continuing for 12 months following termination as applicable.


 


ARTICLE
5 MUTUAL REPRESENTATIONS


 


5.1
The Consultant represents and warrants to the Company that the execution and delivery of this Agreement and the fulfilment of
the terms hereof


 


(a)
will not constitute a default under or conflict with any agreement or other instrument to which he is a party or by which he is
bound; and (b) do not require the consent of any person or entity.


 


5.2
The Company represents and warrants to the Consultant that this Agreement has been duly authorized, executed and delivered by
the Company and that the fulfilment of the terms hereof


 


(a)
will not constitute a default under or conflict with any agreement of other instrument to which it is a party or by which it is
bound; and (b) do not require the consent of any person of entity.


 


5.3
Each party hereto warrants and represents to the other that this Agreement constitutes the valid and binding obligation of such
party enforceable against such party in accordance with its terms subject to applicable bankruptcy, insolvency, moratorium and
similar laws affecting creditors’ rights generally, and subject, as to enforceability, to general principles of equity (regardless
if enforcement is sought in proceeding in equity or at law).


 




    	 



    	7



    

 


ARTICLE
6 NOTICES


 


6.1
Notices. All notices required or allowed to be given under this Agreement must be made either personally by delivery to
or by facsimile transmission to the address as hereinafter set forth or to such other address as may be designated from time to
time by such party in writing:


 


	 	(a)	in
    the case of the Company, to:
	 	 	 
	 	 	Slinger
    Bag Inc.
	 	 	To
    be provided under separate cover within three days after the date hereof; in the event that Consultant does not receive notice
    of address within such period, then Consultant shall be entitled to send any notice to any email address of the Company known
    to Consultant and the sending of any such notice shall constitute receipt of notice whether the Company receives such notice
    or not.


 


	 	(b)	and
    in the case of the Consultant, to the Consultant’s last residence address known to the Company or aitan@gcanrx.com.


 


6.2
Change of Address. Any party may, from time to time, change its address for service hereunder by written notice to the
other party in the manner aforesaid.


 


ARTICLE
7 GENERAL


 


	7.1	Further
    Assurances. Each party hereto will promptly and duly execute and deliver to the other party such further documents and
    assurances and take such further action as such other party may from time to time reasonably request in order to more effectively
    carry out the intent and purpose of this Agreement and to establish and protect the rights and remedies created or intended
    to be created hereby.
	 	 
	7.2	Waiver.
    No provision hereof will be deemed waived and no breach excused, unless such waiver or consent excusing the breach is
    made in writing and signed by the party to be charged with such waiver or consent. A waiver by a party of any provision of
    this Agreement will not be construed as a waiver of a further breach of the same provision.
	 	 
	7.3	Amendments
    in Writing. No amendment, modification or rescission of this Agreement will be effective unless set forth in writing and
    signed by the parties hereto.


 




    	 



    	8



    

 


	7.4	Assignment.
    Except as herein expressly provided, the respective rights and obligations of the Consultant and the Company under this
    Agreement will not be assignable by either party without the written consent of the other party and will, subject to the foregoing,
    inure to the benefit of and be binding upon the Consultant and the Company and their permitted successors or assigns. Nothing
    herein expressed or implied is intended to confer on any person other than the parties hereto any rights, remedies, obligations
    or liabilities under or by reason of this Agreement. For the avoidance of doubt, it is agreed that in the event that the Company
    participates in a merger, acquisition, restructuring, reorganization or other transaction in which the Company is merged into,
    sold to or otherwise becomes part of or owned by another company or entity, this Agreement will remain in force and be binding
    on any such successor, surviving or acquiring company or entity.
	 	 
	7.5	The
    Company acknowledges and agrees that the Consultant may submit to the Company invoices from a company that employs him in
    lieu of invoices on his name. The Consultant confirms that any such invoice will replace his own invoice and he agrees that
    his fees will be paid by the Company to third parties provided that it is done as per his instructions to the Company.
	 	 
	7.6	Severability.
    In the event that any provision contained in this Agreement is declared invalid, illegal or unenforceable by a court or
    other lawful authority of competent jurisdiction, such provision will be deemed not to affect or impair the validity or enforceability
    of any other provision of this Agreement, which will continue to have full force and effect.
	 	 
	7.7	Headings.
    The headings in this Agreement are inserted for convenience of reference only and will not affect the construction or
    interpretation of this Agreement.
	 	 
	7.8	Number
    and Gender. Wherever the singular or masculine or neuter is used in this Agreement, the same will be construed as meaning
    the plural or feminine or a body politic or corporate and vice versa where the context so requires.
	 	 
	7.9	Time.
    Time is of the essence in this Agreement.
	 	 
	7.10	Governing
    Law. This Agreement will be construed and interpreted in accordance with the laws of the State of New York without reference
    to its conflicts of laws principles or the conflicts of laws principles of any other jurisdiction, and each of the parties
    hereto expressly attorns to the jurisdiction of the courts of the State of New York. The sole and exclusive place of jurisdiction
    in any matter arising out of or in connection with this Agreement will be the applicable New York state or federal court.
	 	 
	7.11	This
    Agreement (including all Annexes thereto) constitutes the entire agreement between the Parties with respect to the subject
    matter thereof and supersedes all prior agreements, understandings and negotiations, both written and oral, between the Parties
    with respect to this matter.


 


IN
WITNESS WHEREOF, the parties hereto have executed this Agreement effective as of the date and year first above written.


 


	Slinger
    Bag Inc.	 
	 	 	 
	By:		 
	 	 	 
	Title:	 	 


 


Agreed
and accepted:


 


Aitan
Zacharin


 




    	 



    	9



    

 


Annex
A


 


THIS
WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF ARTICLE 4 BELOW, MAY NOT BE OFFERED, SOLD OR
OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW
OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR
TRANSFER, PLEDGE OR HYPOTHECATION IS EXEMPT FROM REGISTRATION.


 


WARRANT
TO PURCHASE COMMON STOCK


 


Company:
Slinger Bag Inc.


 


Holder:
Aitan Zacharin


 


Shares:
1,250,000 shares of the Company’s common stock.


 


Class
of Stock: common shares of stock of the Company


 


Exercise
Price per share: par value


 


Issue
Date: 30 April 2020


 


Term:
See Section 4.1


 


THIS
WARRANT CERTIFIES THAT, for value received as consideration pursuant to that certain amended and restated service agreement dated
30 April 2020 (the “Service Agreement”) and for other good and valuable consideration the sufficiency of which is
hereby acknowledged, Holder is entitled to receive the Shares in the form of fully paid and nonassessable shares of the Company
at the Exercise Price, all as set forth herein, subject to the provisions and upon the terms and conditions set forth in this
Warrant.


 


ARTICLE
1. EXERCISE.


 


1.1
Method of Exercise. Payment.


 


(a) Cash
Exercise. The purchase rights represented by this Warrant may be exercised by the Holder, in whole or in part, by the
surrender of this Warrant (with the notice of exercise form attached hereto as Appendix 1 duly executed) at the principal office
of the Company, and by the payment to the Company, by certified, cashier’s or other check acceptable to the Company or by
wire transfer to an account designated by the Company, of an amount equal to the aggregate Exercise Price of the Shares being
purchased.


 




    	 



    	10



    

 


(b) Net
Issue Exercise. In lieu of exercising this Warrant, the Holder may elect to receive Shares equal to the value of this
Warrant (or the portion thereof being canceled) by surrender of this Warrant at the principal office of the Company together with
notice of such election, in which event the Company shall issue to the Holder a number of Warrant Shares computed using the following
formula:


 


	 	 	 	 	 	 	 
	 	 	Y
                                         (A-B)

        X
        = ———————

        
	 	 	 	 
	 	 	A	 	 	 	 


 


	Where:	 	X	 	=	 	the
    number of Shares to be issued to the Holder.
	 	 	 	 	 	 	 
	 	 	Y	 	=	 	the
    number of the Shares being exercised on the date of determination.
	 	 	 	 	 	 	 
	 	 	A	 	=	 	the
    fair market value of one Share on the date of determination.
	 	 	 	 	 	 	 
	 	 	B	 	=	 	the
    per share Exercise Price (as adjusted to the date of such calculation).


 


(c)
Fair Market Value. For purposes of this Article 1, the per share fair market value of the Warrant Shares shall mean:


 




    	 



    	11



    

 


(i)
If the Company’s Common Stock is publicly traded, the per share fair market value of the Warrant Shares shall be the average
of the closing prices of the Common Stock as quoted on the Over-the-Counter Bulletin Board, or the principal exchange on which
the Common Stock is listed, in each case for the fifteen trading days ending five trading days prior to the date of determination
of fair market value;


 


(ii)
If the Company’s Common Stock is not so publicly traded, the per share fair market value of the Warrant Shares shall be
such fair market value as is determined in good faith by the Board of Directors of the Company after taking into consideration
factors it deems appropriate, including, without limitation, recent sale and offer prices of the capital stock of the Company
in private transactions negotiated at arm’s length.


 


1.2
Delivery of Certificate and New Warrant. Promptly after Holder first exercises this Warrant, the Company shall deliver
to Holder certificates for or other evidence (reasonably acceptable to the Holder) of the Shares received and, if this Warrant
has not been fully exercised and has not expired, a new Warrant representing the Shares not so received.


 


1.3
Replacement of Warrants. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction
or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably
satisfactory in form and amount to the Company or, in the case of mutilation, on surrender and cancellation of this Warrant, the
Company shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor.


 


ARTICLE
2. ADJUSTMENTS TO THE SHARES.


 


2.1
Stock Dividends, Splits, Combinations, Etc. If the Company declares or pays a dividend on the Shares payable in Common
Stock, or other securities, then upon exercise of this Warrant, for each Share acquired, Holder shall receive, without cost to
Holder, the total number and kind of securities to which Holder would have been entitled had Holder owned the Shares of record
as of the date the dividend occurred. If the Company subdivides the Shares by reclassification or otherwise into a greater number
of shares or takes any other action which increases the amount of stock into which the Shares are convertible, the number of shares
purchasable hereunder shall be proportionately increased and the Exercise Price shall remain the same. If the outstanding shares
of the Company are combined or consolidated, by reclassification or otherwise, into a lesser number of shares, the Exercise Price
shall be proportionately increased and the number of Shares shall be proportionately decreased.


 


2.2
Reclassification, Exchange or Substitution, Etc. Upon any reclassification, exchange, substitution, or other event that
results in a change of the number and/or class of the securities issuable upon exercise or net exercise of this Warrant, Holder
shall be entitled to receive, upon exercise or net exercise of this Warrant, the number and kind of securities and property that
Holder would have received for the Shares if this Warrant had been exercised immediately before such reclassification, exchange,
substitution, or other event. The Company or its successor shall promptly issue to Holder an amendment to this Warrant setting
forth the number and kind of such new securities or other property issuable upon exercise or net exercise of this Warrant as a
result of such reclassification, exchange, substitution or other event that results in a change of the number and/or class of
securities issuable upon exercise or net exercise of this Warrant.


 




    	 



    	12



    

 


2.3
Merger or Consolidation. Upon any capital reorganization of the Company’s capital stock (other than a subdivision,
combination, reclassification or exchange of shares provided for elsewhere in this Section 2) or a merger or consolidation
of the Company with or into another corporation, then as a part of such reorganization, merger or consolidation, provision shall
be made so that the Holder shall thereafter be entitled to receive upon the exercise of this Warrant, the number and kind of securities
and property of the Company, or of the successor corporation resulting from such reorganization, merger or consolidation, to which
that Holder would have received for the Shares if this Warrant had been exercised immediately before such reorganization, merger
or consolidation.


 


2.4
Fractional Shares. No fractional Shares shall be issuable upon exercise or net exercise of this Warrant and the number
of Shares to be issued shall be rounded up to the nearest whole Share.


 


ARTICLE
3. COVENANTS OF THE COMPANY.


 


3.1
Notice of Certain Events. If the Company proposes at any time (a) to declare any dividend or distribution upon any
of its stock, whether in cash, property, stock, or other securities and whether or not a regular cash dividend; (b) to effect
any reclassification or recapitalization of any of its stock; or (c) to merge or consolidate with or into any other corporation,
or sell, lease, license, or convey all or substantially all of its assets, or to liquidate, dissolve or wind up, then, in connection
with each such event, the Company shall give Holder: (1) at least three (3) days prior written notice of the date on
which a record will be taken for such dividend, distribution, or subscription rights (and specifying the date on which the holders
of Common Stock will be entitled thereto) or for determining rights to vote, if any, in respect of the matters referred to in
(a) above; and (2) in the case of the matters referred to in (b) and (c) above at least three (3) days
prior written notice of the date when the same will take place (and specifying the date on which the holders of Common Stock will
be entitled to exchange their Common Stock for securities or other property deliverable upon the occurrence of such event).


 


3.2
No Stockholder Rights or Liabilities. Except as provided in this Warrant, the Holder will not have any rights as a stockholder
of the Company until the exercise of this Warrant. Absent an affirmative action by the Holder to purchase the Shares, the Holder
shall not have any liability as a stockholder of the Company.


 


3.3
Closing of Books. The Company will at no time close its transfer books against the transfer of this Warrant or of any Shares
issued or issuable upon the exercise of this Warrant in any manner which interferes with the timely exercise of this Warrant.


 


ARTICLE
4. MISCELLANEOUS.


 


4.1
Term. This Warrant is exercisable in whole or in part at any time and from time to time on or before the earlier of 5:00
pm GMT on the tenth (10th) anniversary of the Issue Date.


4.2
Legends. This Warrant and the Shares (and the securities issuable, directly or indirectly, upon conversion of the Shares,
if any) shall be imprinted with a legend in substantially the following form:


 


THIS
WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND
UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE
SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS EXEMPT FROM REGISTRATION.


 




    	 



    	13



    

 


4.3
Transfers. This Warrant and the Shares issuable upon exercise of this Warrant (and the securities issuable, directly or
indirectly, upon conversion of the Shares, if any) may not be transferred or assigned in whole or in part without compliance with
applicable federal and state securities laws by the transferor and the transferee (including, without limitation, the delivery
of investment representation letters and legal opinions reasonably satisfactory to the Company, as reasonably requested by the
Company). After compliance with all restrictions on transfer set forth in this Section 4.3, and within a reasonable time
after the Company’s receipt of an executed assignment agreement, the transfer shall be recorded on the books of the Company
upon the surrender of this Warrant, properly endorsed, to the Company at its principal offices, and the payment to the Company
of all transfer taxes and other governmental charges imposed on such transfer. In the event of a partial transfer, the Company
shall issue to the new holders one or more appropriate new warrants.


 


4.4
Notices. All notices and other communications from the Company to the Holder, or vice versa, shall be deemed delivered
and effective when given personally or mailed by first-class registered or certified mail, postage prepaid, at such address as
may have been furnished to the Company or the Holder, as the case may (or on the first business day after transmission by facsimile)
be, in writing by the Company or such Holder from time to time. Effective upon receipt of the fully executed Warrant, all notices
to the Holder shall be addressed as set forth on the signature page hereto until the Company receives notice of a change of address
in connection with a transfer or otherwise. Notice to the Company shall be addressed as set forth on the signature page hereto
until the Holder receives notice of a change in address.


 


4.5
Waiver. This Warrant and any term hereof may be changed, waived, discharged or terminated only by an instrument in writing
signed by the party against which enforcement of such change, waiver, discharge or termination is sought.


 


4.6
Counterparts. This Warrant may be executed in counterparts, all of which together shall constitute one and the same agreement.


 


4.7
Governing Law. This Warrant shall be governed by and construed in accordance with the laws of the State of New York, without
giving effect to its principles regarding conflicts of law.


 


Please
indicate your acceptance of these terms by countersigning where indicated below.


 





	Slinger
    Bag Inc.
	 
	 	 
	Name:	 	 
	Title:	 	 
	 	 	 
	Agreed
    and accepted:
	 	 	 
	Aitan
    Zacharin




 







    	 



    	14



    

 


Appendix
1


 


SLINGER
BAG INC.


 


EXERCISE
NOTICE


 


Reference
is made to the Warrant Agreement dated 30 April 2020 between Slinger Bag Inc. (the “Company”) and Aitan Zacharin (the
“Warrant Agreement”). In accordance with and pursuant to the Warrant Agreement, the undersigned hereby elects to exercise
the Warrant to purchase shares of common stock of the Company as set forth below. Capitalized terms used but not defined herein
have the meanings assigned to such terms in the Warrant Agreement.


 


Date
of


Exercise:
__________________________________________________



 


Number
of shares of ordinary/common


(or
its equivalent) stock to be purchased:________________________________



 


Please
issue shares of common stock in the following name and to the following address:


 


Issue
to: _________________________________________


 


Address:
_________________________________________


 


Telephone
Number: ________________________________


 


Email
address: _________________________________


 


Holder:
__________________________________________


 


	 	By:	 
	 	Title: